Clinical Trial Update: Study of the Combination of CM082 With JS001 in Patients With Advanced Mucosal Melanoma. [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the combination of CM082 with JS001 in patients with advanced mucosal melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucosal Melanoma

Drugs mentioned

• CM082
• JS001 (PD-1 inhibitor)

Snippet

Sponsor: AnewPharma | Conditions: Mucosal Melanoma | Phase 2 | Status: UNKNOWN